Prediction of initial objective response to drug-eluting beads transcatheter arterial chemoembolization for hepatocellular carcinoma using CT radiomics-based machine learning model

被引:4
|
作者
Zhang, Xueying [1 ]
He, Zijun [1 ]
Zhang, Yucong [2 ]
Kong, Jian [3 ]
机构
[1] Jinan Univ, Clin Med Coll 2, Shenzhen, Guangdong, Peoples R China
[2] Southern Univ Sci & Technol, Jinan Univ, Shenzhen Peoples Hosp,Clin Med Coll 2, Dept Radiat Oncol,Affiliated Hosp 1, Shenzhen, Guangdong, Peoples R China
[3] Southern Univ Sci & Technol, Jinan Univ, Shenzhen Peoples Hosp,Affiliated Hosp 1, Dept Intervent Radiol,Clin Med Coll 2, Shenzhen, Guangdong, Peoples R China
关键词
hepatocellular carcinoma; drug-eluting beads transcatheter arterial chemoembolization; initial response; objective response; computed tomography; radiomics; nomogram; prediction; TRANSARTERIAL CHEMOEMBOLIZATION; LIVER-CANCER; TIME-POINT; DC BEAD; MRECIST; CLASSIFICATION; SURVIVAL; HETEROGENEITY; SYSTEM; EASL;
D O I
10.3389/fphar.2024.1315732
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: A prognostic model utilizing CT radiomics, radiological, and clinical features was developed and validated in this study to predict an objective response to initial transcatheter arterial chemoembolization with drug-eluting beads (DEB-TACE) for hepatocellular carcinoma (HCC).Methods: Between January 2017 and December 2022, the baseline clinical characteristics and preoperative and postoperative follow-up imaging data of 108 HCC patients who underwent the first time treatment of DEB-TACE were analyzed retrospectively. The training group (n = 86) and the validation group (n = 22) were randomly assigned in an 8:2 ratio. By logistic regression in machine learning, radiomics, and clinical-radiological models were constructed separately. Finally, the integrated model construction involved the integration of both radiomics and clinical-radiological signatures. The study compared the integrated model with radiomics and clinical-radiological models using calibration curves, receiver operating characteristic (ROC) curves, and decision curve analysis (DCA).Results: The objective response rate observed in a group of 108 HCC patients who received initial DEB-TACE treatment was found to be 51.9%. Among the three models, the integrated model exhibited superior predictive accuracy in both the training and validation groups. The training group resulted in an area under the curve (AUC) of 0.860, along with sensitivity and specificity values of 0.650 and 0.913, respectively. Based on the findings from the validation group, the AUC was estimated to be 0.927. Additionally, it was found that values of sensitivity and specificity were 0.875 and 0.833, respectively. In the validation group, the AUC of the integrated model showed a significant improvement when contrasted to the clinical-radiological model (p = 0.042). Nevertheless, no significant distinction was observed in the AUC when comparing the integrated model with the radiomics model (p = 0.734). The DCA suggested that the integrated model demonstrates advantageous clinical utility.Conclusion: The integrated model, which combines the CT radiomics signature and the clinical-radiological signature, exhibited higher predictive efficacy than either the radiomics or clinical-radiological models alone. This suggests that during the prediction of the objective responsiveness of HCC patients to the first DEB-TACE treatment, the integrated model yields superior outcomes.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Tumor Response and Nomogram-Based Prognostic Stratification for Hepatocellular Carcinoma After Drug-Eluting Beads Transarterial Chemoembolization
    Ji, Kun
    Zhu, Hanlong
    Wu, Wei
    Li, Xin
    Zhan, Pengchao
    Shi, Yang
    Sun, Junhui
    Li, Zhen
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2022, 9 : 537 - 551
  • [2] Apparent Diffusion Coefficient as a Noninvasive Biomarker for the Early Response in Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Using Drug-eluting Beads
    Li, Basen
    Zhou, Lei
    Xu, Anhui
    Li, Qin
    Xiang, Huihua
    Huang, Yanrong
    Peng, Ling
    Xiang, Kun
    Zhang, Mingfeng
    Wang, Nan
    CURRENT MEDICAL IMAGING, 2022, 18 (11) : 1186 - 1194
  • [3] The update on transcatheter arterial chemoembolization using drug-eluting beads: Optimization for best response
    Oh, Jung Suk
    Chun, Ho Jong
    INTERNATIONAL JOURNAL OF GASTROINTESTINAL INTERVENTION, 2021, 10 (04): : 161 - 164
  • [4] Hemobilia immediately after transcatheter arterial chemoembolization using drug-eluting beads for hepatocellular carcinoma with intrahepatic bile duct invasion
    Nishi, Maiko
    Saeki, Issei
    Yamasaki, Takahiro
    Maeda, Masaki
    Hisanaga, Takuro
    Iwamoto, Takuya
    Matsumoto, Toshihiko
    Hidaka, Isao
    Ishikawa, Tsuyoshi
    Takami, Taro
    Sakaida, Isao
    HEPATOLOGY RESEARCH, 2018, 48 (04) : 329 - 332
  • [5] The clinical safety and efficacy of conventional transcatheter arterial chemoembolization and drug-eluting beads-transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A meta-analysis
    Han, Tao
    Yang, Xiaodan
    Zhang, Yue
    Li, Gao
    Liu, Lu
    Chen, Tingsong
    Zheng, Zhendong
    BIOSCIENCE TRENDS, 2019, 13 (05) : 374 - 381
  • [6] Advanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization
    Gorodetski, Boris
    Chapiro, Julius
    Schernthaner, Ruediger
    Duran, Rafael
    Lin, MingDe
    Lee, Howard
    Lenis, David
    Stuart, Elizabeth A.
    Nonyane, Bareng Aletta Sanny
    Pekurovsky, Vasily
    Tamrazi, Anobel
    Gebauer, Bernhard
    Schlachter, Todd
    Pawlik, Timothy M.
    Geschwind, Jean-Francois
    EUROPEAN RADIOLOGY, 2017, 27 (02) : 526 - 535
  • [7] Transcatheter Arterial Chemoembolization with Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma: Recommended Selection for Small-Caliber (<100 μm) Beads
    Chang, Wei-Chou
    Hsu, Hsian-He
    Chiu, Sung-Hua
    Huang, Wen-Yen
    Lo, Cheng-Hsiang
    Lin, Hsuan-Hwai
    Huang, Pei-Ching
    Shih, Yu-Lueng
    Wan, Yung-Liang
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2021, 8 : 937 - 949
  • [8] A Machine Learning Model to Predict Hepatocellular Carcinoma Response to Transcatheter Arterial Chemoembolization
    Morshid, Ali
    Elsayes, Khaled M.
    Khalaf, Ahmed M.
    Elmohr, Mohab M.
    Yu, Justin
    Kaseb, Ahmed O.
    Hassan, Manal
    Mahvash, Armeen
    Wang, Zhihui
    Hazle, John D.
    Fuentes, David
    RADIOLOGY-ARTIFICIAL INTELLIGENCE, 2019, 1 (05)
  • [9] Initial Experience of Drug-Eluting Bead-Transcatheter Arterial Chemoembolization After Lipiodol-Based Transcatheter Arterial Chemoembolization Failure for Patients with Advanced Hepatocellular Carcinoma
    Liu, Kai-Cai
    Lv, Wei-Fu
    Lu, Dong
    Hou, Chang-Long
    Xie, Jun
    Lu, Yu-He
    Cao, Qi-Sheng
    Tan, Yu-Lin
    Zhang, Ying-Zhan
    Liu, Jie
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 7973 - 7980
  • [10] Predictive factors for complete response of chemoembolization with drug-eluting beads (DEB-TACE) for hepatocellular carcinoma
    Vesselle, Guillaume
    Quirier-Leleu, Camille
    Velasco, Stephane
    Charier, Florian
    Silvain, Christine
    Boucebci, Samy
    Ingrand, Pierre
    Tasu, Jean-Pierre
    EUROPEAN RADIOLOGY, 2016, 26 (06) : 1640 - 1648